A number of pharmacies suspended Zantac sales after the discovery of a known carcinogen
Call now to find out if you qualify
Chemically known as ranitidine hydrochloride, Zantac is a very popular antacid medication that has been on the market since the early 1980s. Zantac is available over the counter (Zantac OTC) and by prescription. People commonly use Zantac for acid reflux, heartburn, and a host of other stomach, throat, and gastrointestinal issues. Others use Zantac for allergies to supplement their treatment regimen.
Zantac dosage varies between 75 and 150 mg tablets, though some patients take a once daily Zantac 300 mg dosage.
In 2019, Valisure, an online pharmacy company, alerted the FDA that it had found high levels of NDMA in Ranitidine. Valisure filed a Citizen Petition with the FDA asking the agency to pull all ranitidine products from the shelves. It also requested that the FDA create methods for testing ranitidine drugs for NDMA.
In response to this petition, the FDA conducted “early, limited testing” on drugs and found unacceptable levels of NDMA in them. Now, the largest pharmacies in the nation are pulling ranitidine drugs from their shelves. Walgreens, CVS, and Rite Aid have suspended all sales of Zantac and its generic equivalents.
If you or a loved one regularly used Zantac and were then diagnosed with:
You may be entitled to significant compensation from the manufacturer.
There are time deadlines to file a claim so don’t wait – act now.
Do not stop taking a prescribed medication without first consulting your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.